Pathogen persistence occurs when microbes remain hidden in body tissues, evading detection and disrupting immune function, metabolism, and gene activity—which can make diagnosis and treatment challenging.

What are IACIs—and why should more clinicians and science communicators be paying attention? Infection-Associated Chronic Illnesses (IACIs) like Long COVID, ME/CFS, and Post-Treatment Lyme Disease Syndrome can develop after viral, bacterial, or fungal infections. These conditions are disabling, com

Attention science and health communicators: We are hosting our first informational session dedicated to helping you share about infection-associated chronic illnesses like Long COVID, ME/CFS, and post-treatment Lyme disease syndrome. Reach out to [email protected] for more info!

Participate in research aimed at uncovering the role of antiviral medications in treating Long COVID. For participation details, contact [email protected].

Be part of a clinical trial evaluating a new device for chronic pain and sleep disturbances in individuals with post-treatment Lyme disease. Contact [email protected] for more information.

Be part of a 180-day trial testing the effects of Truvada and Miraviroc on chronic symptoms. For more information, email [email protected].

Be part of a clinical trial investigating the effects of a neurotech device on cognitive function in Long COVID. For more information, contact [email protected].

Join our study on the Sana device for chronic pain management related to post-treatment Lyme disease. For details, email [email protected].

Help us evaluate the effectiveness of two antiviral medications in reducing Long COVID symptoms. For participation inquiries, contact [email protected].

Join our study focused on a device aimed at improving cognitive dysfunction in Long COVID patients. For inquiries, email [email protected].

Help us understand the impact of the Sana Health device on chronic pain and sleep disturbances. Interested participants can inquire at [email protected].

Participate in a clinical trial assessing the impact of Truvada and Miraviroc on chronic symptoms in adults with Long COVID. Email [email protected] for more information.

Help us assess the impact of a novel device on cognitive function in individuals with Long COVID. Contact [email protected] for participation details.

Participate in research evaluating the effects of Lumbrokinase on chronic illness symptoms. For details, reach out to [email protected].

Join a 14-week trial assessing the Sana device's effectiveness in managing pain and sleep issues in post-treatment Lyme disease patients. For more information, contact [email protected].

Participate in research evaluating the effects of sirolimus on chronic illness symptoms. For inquiries, reach out to [email protected].

Join our study focused on the potential benefits of repurposed HIV antivirals for managing Long COVID. For details, reach out to [email protected].

Participate in a trial evaluating a new device for cognitive dysfunction related to Long COVID. For more information, reach out to [email protected].

Help us assess the impact of Lumbrokinase on symptom burden in Long COVID and related conditions. Email [email protected] for participation details.

Participate in a study examining the effects of a novel device on chronic pain related to post-treatment Lyme disease. Email [email protected] to see if you qualify.

Help us assess the impact of sirolimus on chronic symptoms in individuals with Long COVID. Email [email protected] for participation details.

Be part of a trial testing the efficacy of Truvada and Miraviroc on Long COVID symptoms. Contact [email protected] to find out more about participation requirements.

Join our study assessing the safety and efficacy of a neurotech device for cognitive dysfunction in Long COVID. Email [email protected] for details.

Join our trial testing the dietary supplement Lumbrokinase for its effects on chronic symptoms. For more information, contact [email protected].

Be part of a trial investigating the Sana Health device's impact on chronic pain and sleep disturbances. Contact [email protected] for participation information.

Join our trial testing the efficacy of sirolimus in adults with Long COVID. For details, contact [email protected].

We're exploring the effects of two antiviral medications on Long COVID symptoms. For more information, email [email protected].

Be part of a clinical trial investigating a device designed to assist cognitive function in Long COVID patients. For more information, contact [email protected].

Be part of a study investigating the potential benefits of Lumbrokinase for chronic illness management. For inquiries, email [email protected].

Are you experiencing chronic pain after Lyme disease treatment? Participate in a study evaluating a new therapeutic device. For details, reach out to [email protected].

Be part of a study investigating the potential benefits of sirolimus for managing Long COVID symptoms. For more information, email [email protected].

Help advance research on Long COVID by participating in a trial utilizing Truvada and Miraviroc. Interested individuals can inquire at [email protected].

Join our study on the effectiveness of a new device for cognitive dysfunction associated with Long COVID. For inquiries, email [email protected].

Participate in research assessing the effects of Lumbrokinase on symptom relief in individuals with Long COVID and related conditions. Contact [email protected] for more information.

Help us explore the effectiveness of the Sana device in managing chronic pain and sleep issues in individuals with post-treatment Lyme disease syndrome. Inquire at [email protected].

Participate in research assessing the impact of sirolimus on symptom relief in Long COVID patients. For inquiries, contact [email protected].

Join a study evaluating the potential of two repurposed HIV antivirals to alleviate Long COVID symptoms. The trial lasts 180 days. Email [email protected] for details.

Help us evaluate a novel device aimed at improving cognitive function in individuals with Long COVID. Contact [email protected] for details.

Help us evaluate the impact of Lumbrokinase on chronic illness symptoms in a clinical trial. For details, email [email protected].

Participate in a 14-week study assessing a novel device aimed at alleviating chronic pain associated with post-treatment Lyme disease. For more information, email [email protected].

Help us evaluate the effects of sirolimus on chronic symptoms in individuals with Long COVID. Email [email protected] for details.

Participate in a trial testing the effectiveness of Truvada and Miraviroc in reducing symptoms of Long COVID. For more information, contact [email protected].

Participate in a clinical trial assessing the feasibility of an at-home device for cognitive dysfunction related to Long COVID. For more information, email [email protected].

Join a study testing the dietary supplement Lumbrokinase for its effects on symptom burden in Long COVID, post-treatment Lyme disease, and ME/CFS. For more information, contact [email protected].

Join our randomized control trial to evaluate the Sana Health device's effects on chronic neuropathic pain and sleep disturbances related to post-treatment Lyme disease. Contact [email protected] for details.

Join a clinical trial assessing the safety and efficacy of sirolimus in adults with Long COVID. For more information, contact [email protected].

Help advance research on Long COVID by participating in a trial utilizing Truvada and Miraviroc. Interested individuals can inquire at [email protected].

Join our study on the effectiveness of a new device for cognitive dysfunction associated with Long COVID. For inquiries, email [email protected].

Join our study on the effectiveness of a new device for cognitive dysfunction associated with Long COVID. For inquiries, email [email protected].

Participate in research assessing the effects of Lumbrokinase on symptom relief in individuals with Long COVID and related conditions. Contact [email protected] for more information.